All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Trade association for medical device manufacturers.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 5, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

ALANNA TEMME

Previously held: Legislative Director, U.S. Representative Jon Porter
SOPHIE KHANAHMADI

Previously held: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).

Medicare/Medicaid

Access to and reimbursement of medical devices in Medicare program. Issues related to Medicare coverage reform. Issues related to Medicare coverage for digital health technologies. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers. Issues related to CMS expansion of prior authorization requirements for medical procedures.

Bills named in this filing 1

H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.